« Previous
Next »
Metabolism - Clinical and Experimental
Volume 44, Issue 11
, Pages 1410-1412
, November 1995
Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia
References
- Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 1990;323:224–228
- . Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: Relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. J Lipid Res. 1981;22:410–422
- . Clofibrate and gallstones. Lancet. 1975;1:1083
- . Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res. 1981;22:24–36
- . Gallbladder diseases as a side effect of drugs. N Engl J Med. 1977;296:1185
- Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology. 1988;8:1147–1150
- . Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology. 1990;98:1572–1578
- Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolemia. Gut. 1990;31:348–350
- Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia. Hepatology. 1992;15:1072–1078
-
.
Nucleation time and fatty acid composition of lecithin in human gallbladder bile.
Scand J Gastroenterol. 1993;23:131–136
- Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs. Digestion. 1992;51:179–184
- Simultaneous microanalysis of biliary cholesterol, bile acids and fatty acids in lecithin using capillary column gas chromatography: An advantage to assess bile lithogenicity. J Chromatogr. 1994;653:1–7
- . Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res. 1978;19:945–955
- Intestinal HMG-CoA reductase activity is low in hypercholesterolemic patients and is further decreased with lovastatin therapy. J Lipid Res. 1988;29:839–841
- Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. J Gastroenterol. 1994;29:47–55
- . The properties of polyunsaturated lecithins in monolayers and liposomes and the interactions of these lecithins with cholesterol. Biochim Biophys Acta. 1972;266:26–40
- . Acyl chain unsaturation modulates distribution of lecithin molecular species between mixed micelles and vesicles in model bile. In: Implications for particle structure and metastable cholesterol solubilities. ed 3. J Lipid Res. 32:1991;p. 1291–1302
- . Fatty acid composition of lecithin is a key factor in bile metastability in supersaturated model bile systems. Biochim Biophys Acta. 1993;1167:142–146
- Degree of fatty acyl chain unsaturation in biliary lecithin dictates cholesterol nucleation and crystal growth. Biochim Biophys Acta. 1994;1215:74–78
PII: 0026-0495(95)90138-8
« Previous
Next »
Metabolism - Clinical and Experimental
Volume 44, Issue 11
, Pages 1410-1412
, November 1995
